Thermal ablation with and without adjuvant systemic therapy: a nationwide multicenter observational cohort study of solitary colorectal liver metastases

CONCLUSIONS: For patients with plasma CEA >5 ug/L, T (III-IV) category of primary cancer, or clinical risk score (1-2), thermal ablation plus systemic therapy appeared to be associated with improved overall survival. Thermal ablation was equally effective in disease-free survival for treating solitary colorectal liver metastasis, whether with or without adjuvant systemic therapy.PMID:38597399 | DOI:10.1097/JS9.0000000000001397

Source: Cancer Control - April 10, 2024 Category: Cancer & Oncology Authors: Jianming Li Chuan Pang Guangjian Liu Xiaoyan Xie De-Zhi Zhang Kai Li Zhishuai Li Guangbin He Erjiao Xu Huage Zhong Hong Yang Man Lu Kexin Lou Xiang Xie Sirong Lan Qian Li Guanghai Dai Jie Yu Ping Liang Source Type: research